Human A4GALT ELISA Kit (V2LY-0626-LY4790)

Westman, J. S., Stenfelt, L., Vidovic, K., Möller, M., Hellberg, Å., Kjellström, S., & Olsson, M. L. (2018). Allele-selective RUNX1 binding regulates P1 blood group status by transcriptional control of A4GALT. Blood, The Journal of the American Society of Hematology, 131(14), 1611-1616.

Yeh, C. C., Chang, C. J., Twu, Y. C., Hung, S. T., Tsai, Y. J., Liao, J. C., ... & Yu, L. C. (2018). The differential expression of the blood group P1‐A4GALT and P2‐A4GALT alleles is stimulated by the transcription factor early growth response 1. Transfusion, 58(4), 1054-1064.

Kaczmarek, R., Szymczak-Kulus, K., Bereźnicka, A., Mikołajczyk, K., Duk, M., Majorczyk, E., ... & Czerwinski, M. (2018). Single nucleotide polymorphisms in A4GALT spur extra products of the human Gb3/CD77 synthase and underlie the P1PK blood group system. PloS one, 13(4), e0196627.

Maruyama, H., Taguchi, A., Nishikawa, Y., Guili, C., Mikame, M., Nameta, M., ... & Ishii, S. (2018). Medullary thick ascending limb impairment in the GlatmTg (CAG‐A4GALT) Fabry model mice. The FASEB Journal, 32(8), 4544-4559.

Shastry, S., Satyamoorthy, K., Acharya, K. V., Reddy, V. R., Mohan, G., Deepika, C., ... & Joshi, M. B. (2020). Deletion in the A4GALT gene associated with Rare “P null” phenotype: The first report from India. Transfusion Medicine and Hemotherapy, 47(2), 186-189.

Thinley, J., Nathalang, O., Chidtrakoon, S., & Intharanut, K. (2021). Blood group P1 prediction using multiplex PCR genotyping of A4GALT among Thai blood donors. Transfusion Medicine, 31(1), 48-54.

Maruyama, H., Taguchi, A., Mikame, M., Lu, H., Tada, N., Ishijima, M., ... & Ishii, S. (2020). Low bone mineral density due to secondary hyperparathyroidism in the GlatmTg (CAG‐A4GALT) mouse model of Fabry disease. FASEB BioAdvances, 2(6), 365-381.

Chen, Q., Xiao, J., Duan, Z., Shi, L., Huang, C., & Li, M. (2021). Novel A4GALT gene variation with rare p phenotype in a compound heterozygous Chinese individual. Transfusion, 61(1), E5-E6.

Jacob, F., Alam, S., Liang, C. Y., Kohler, R., Nonantz, M., Everest-Dass, A., ... & Heinzelmann-Schwarz, V. (2018). A4GALT-related glycosphingolipids play a pivotal role in the reversible transition of mesenchymal and epithelial ovarian cancer cells and hence are important regulators of metastasis. Geburtshilfe und Frauenheilkunde, 78(10), P-152.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols